Gastrointestinal tolerability of once-daily galantamine in subjects with mild-to-moderate Alzheimer's disease

被引：0

作者：

Dunbar, F ^{[1
]}

Zhu, Y ^{[1
]}

Brashear, R ^{[1
]}

机构：

[1] Janssen Ortho Inc, Toronto, ON, Canada

来源：

INTERNATIONAL PSYCHOGERIATRICS | 2005年 / 17卷

关键词：

D O I：

暂无

中图分类号：

B849 [应用心理学];

学科分类号：

040203 ;

摘要：

引用

页码：312 / 312

页数：1

共 50 条

[1] Once-daily galantamine provides improved upper gastrointestinal tolerability in patients with mild to moderate Alzheimer's disease
Dunbar, F
Zhu, Y
Brashear, HR
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S279 - S280
[2] Safety and tolerability of once-daily galantamine extended release in patients with mild to moderate Alzheimer's disease
Brodaty, H
Schwalen, S
Gold, M
[J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S209 - S209
[3] Safety and tolerability of once-daily galantamine prolonged-release in patients with mild to moderate Alzheimer's disease
Brodaty, H.
Yan, B.
Damaraju, C. V.
Gold, M.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 188 - 188
[4] Once-daily galantamine maintains activities of daily living performance in people with mild to moderate Alzheimer's disease
Dunbar, F.
Zhu, Y.
Brashear, H. R.
Binder, C.
Hammond, G.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 192 - 193
[5] Efficacy of once-daily galantamine extended-release in patients with mild to moderate Alzheimer's disease
Brodaty, H
Yan, B
Damaraju, CRV
[J]. NEUROLOGY, 2004, 62 (07) : A317 - A318
[6] Galantamine prolonged-release formulation permits once-daily dosing in patients with mild to moderate Alzheimer's disease
Brodaty, H
Schwalen, S
Gold, M
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S333 - S334
[7] Tolerability and efficacy of once-daily galantamine extended-release in patients with mild to moderate AD.
Corey-Bloom, J
Yan, B
Damaraju, CV
[J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S127 - S127
[8] Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease
Seltzer, Ben
[J]. CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 1 - 6
[9] Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease
Bennett, James
Burns, Jeffrey
Welch, Paul
Bothwell, Rebecca
[J]. JOURNAL OF ALZHEIMERS DISEASE, 2016, 49 (04) : 1179 - 1187
[10] Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension
Kuppers, HE
Jager, BA
Luszick, JH
Grave, MA
Hughes, PR
Kaan, EC
[J]. JOURNAL OF HYPERTENSION, 1997, 15 (01) : 93 - 97

← 1 2 3 4 5 →